reboxetine has been researched along with opipramol in 1 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (opipramol) | Trials (opipramol) | Recent Studies (post-2010) (opipramol) |
---|---|---|---|---|---|
626 | 193 | 184 | 259 | 27 | 21 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Holoubek, G; Müller, WE | 1 |
1 other study(ies) available for reboxetine and opipramol
Article | Year |
---|---|
Specific modulation of sigma binding sites by the anxiolytic drug opipramol.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Brain; Cell Membrane; Citalopram; Imipramine; Male; Morpholines; Opipramol; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, beta; Receptors, Serotonin, 5-HT2; Receptors, sigma; Swimming | 2003 |